I reckon there will be bigger days in the near future, today was a taste tester. Well done to all the long term and new holders.
Seems like management are pushing towards the concrete additive path in the near term. Ever since the 1st ann around the 5c range ( from memory ), regarding concrete. The buying has been big and very consistent. The buying this morning that took out the 20-22 walls only suggest this is going in one direction. There will be pull backs, it’s all part of the game.
The most exciting part for ADN is the blue sky potential pathways. It’s such an unknown in terms of demand, so I can’t see much of the blue sky factored into the sp yet. I suspect the demand will be huge over the next few years.
Today I hit 40 bags from my initial investment, my life has changed because of this company. We definitely need to stay level headed and trust management with their decisions they make. Enjoy the weekend
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-12831
-
- There are more pages in this discussion • 31,248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $49.76M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.5¢ | $92.09K | 5.787M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 3456624 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 0.016 |
43 | 7873041 | 0.015 |
15 | 5136049 | 0.014 |
7 | 2633923 | 0.013 |
6 | 1655833 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 3456624 | 11 |
0.018 | 2962774 | 10 |
0.019 | 3659762 | 9 |
0.020 | 1678444 | 14 |
0.021 | 1397619 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online